322 related articles for article (PubMed ID: 28247946)
1. The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy.
Moore C; Kosgodage U; Lange S; Inal JM
Int J Cancer; 2017 Aug; 141(3):428-436. PubMed ID: 28247946
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?
Lange S; Gallagher M; Kholia S; Kosgodage US; Hristova M; Hardy J; Inal JM
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587234
[TBL] [Abstract][Full Text] [Related]
3. Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy.
Kosgodage US; Trindade RP; Thompson PR; Inal JM; Lange S
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486412
[TBL] [Abstract][Full Text] [Related]
4. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
Sundararajan V; Sarkar FH; Ramasamy TS
Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
[TBL] [Abstract][Full Text] [Related]
5. Exosome/microvesicle content is altered in leucine-rich repeat kinase 2 mutant induced pluripotent stem cell-derived neural cells.
Candelario KM; Balaj L; Zheng T; Skog J; Scheffler B; Breakefield X; Schüle B; Steindler DA
J Comp Neurol; 2020 May; 528(7):1203-1215. PubMed ID: 31743443
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer.
Kosgodage US; Mould R; Henley AB; Nunn AV; Guy GW; Thomas EL; Inal JM; Bell JD; Lange S
Front Pharmacol; 2018; 9():889. PubMed ID: 30150937
[TBL] [Abstract][Full Text] [Related]
7. Complex N-linked glycans serve as a determinant for exosome/microvesicle cargo recruitment.
Liang Y; Eng WS; Colquhoun DR; Dinglasan RR; Graham DR; Mahal LK
J Biol Chem; 2014 Nov; 289(47):32526-37. PubMed ID: 25261472
[TBL] [Abstract][Full Text] [Related]
8. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
Syn NL; Wang L; Chow EK; Lim CT; Goh BC
Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
[TBL] [Abstract][Full Text] [Related]
9. The immunogenicity of dendritic cell-derived exosomes.
Quah BJ; O'Neill HC
Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
[TBL] [Abstract][Full Text] [Related]
10. Consideration of dual characters of exosomes in the tumour immune response.
Bai J; Xie X; Lei Y; An G; He L; Chen R
Cell Biol Int; 2014 Apr; 38(4):538-45. PubMed ID: 24523154
[TBL] [Abstract][Full Text] [Related]
11. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
Alfonsi R; Grassi L; Signore M; Bonci D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
[TBL] [Abstract][Full Text] [Related]
12. Role of exosomes/microvesicles in the nervous system and use in emerging therapies.
Lai CP; Breakefield XO
Front Physiol; 2012; 3():228. PubMed ID: 22754538
[TBL] [Abstract][Full Text] [Related]
13. Fibroblasts Rendered Antifibrotic, Antiapoptotic, and Angiogenic by Priming With Cardiosphere-Derived Extracellular Membrane Vesicles.
Tseliou E; Fouad J; Reich H; Slipczuk L; de Couto G; Aminzadeh M; Middleton R; Valle J; Weixin L; Marbán E
J Am Coll Cardiol; 2015 Aug; 66(6):599-611. PubMed ID: 26248985
[TBL] [Abstract][Full Text] [Related]
14. The cis-acting signals that target proteins to exosomes and microvesicles.
Yang JM; Gould SJ
Biochem Soc Trans; 2013 Feb; 41(1):277-82. PubMed ID: 23356297
[TBL] [Abstract][Full Text] [Related]
15. The emerging roles of exosomes in leukemogeneis.
Zhou J; Wang S; Sun K; Chng WJ
Oncotarget; 2016 Aug; 7(31):50698-50707. PubMed ID: 27191983
[TBL] [Abstract][Full Text] [Related]
16. Exosomal cancer immunotherapy is independent of MHC molecules on exosomes.
Hiltbrunner S; Larssen P; Eldh M; Martinez-Bravo MJ; Wagner AK; Karlsson MC; Gabrielsson S
Oncotarget; 2016 Jun; 7(25):38707-38717. PubMed ID: 27231849
[TBL] [Abstract][Full Text] [Related]
17. Transfer of microRNAs by extracellular membrane microvesicles: a nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions.
Zhang L; Valencia CA; Dong B; Chen M; Guan PJ; Pan L
J Hematol Oncol; 2015 Feb; 8():14. PubMed ID: 25885907
[TBL] [Abstract][Full Text] [Related]
18. Tumour-released exosomes and their implications in cancer immunity.
Iero M; Valenti R; Huber V; Filipazzi P; Parmiani G; Fais S; Rivoltini L
Cell Death Differ; 2008 Jan; 15(1):80-8. PubMed ID: 17932500
[TBL] [Abstract][Full Text] [Related]
19. A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications.
Knox MC; Ni J; Bece A; Bucci J; Chin Y; Graham PH; Li Y
Front Immunol; 2020; 11():1612. PubMed ID: 32793238
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the exosome-induced immune response for cancer immunotherapy.
Gehrmann U; Näslund TI; Hiltbrunner S; Larssen P; Gabrielsson S
Semin Cancer Biol; 2014 Oct; 28():58-67. PubMed ID: 24859748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
